BioSpace News Archive

AstraZeneca spinout Albireo Pharma is moving closer to securing regulatory approval for its treatment known as odevixibat, for pruritus in patients with PFIC.

T cell company TScan Therapeutics announced it will push two cancer therapies into the clinic this year thanks to a $100 million Series C round.

Moderna announced it has started development on a booster to its COVID-19 vaccine, which the company hopes will work against the recently discovered (and more transmissible) SARS-CoV-2 variant from South Africa.

Pfizer, Moderna, AstraZeneca, and Johnson & Johnson all have trials of their respective vaccines underway in various age-groups.

Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021

Every three minutes around the world, a child is diagnosed with cancer. In the United States, cancer remains the leading cause of death by disease for children, with brain tumors being the deadliest. Despite these statistics, a new drug has never been developed and approved specifically for pediatric brain cancer.

The Tauri-Gum™ Product Line Now Consists of 7 SKUs: Pomegranate (CBD), Blood Orange (CBD), Peach-Lemon (CBG), Pear Bellini (Vitamin C & Zinc), Mint (CBD), Black Currant (CBG), Cherry Lime Rickey (Caffeine)

London, United Kingdom--(Newsfile Corp. - January 25, 2021) - Awakn Life Sciences Inc., a biotechnology company focused on research, development, and delivery of psychedelic medicines for the treatment of mental health conditions, today announced the appointment of James Collins as Chief Operating Officer, effective January 2021.

AbbVie (NYSE: ABBV), today announced that the European Commission (EC) has approved RINVOQTM (upadacitinib, 15 mg), an oral, once daily selective and reversible JAK inhibitor for the treatment of active psoriatic arthritis (PsA) in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate

ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital®, announced several new hires to its senior leadership team, effective immediately.